Logo image of APRN

BLUE APRON HOLDINGS INC-A (APRN) Stock Fundamental Analysis

NASDAQ:APRN - Nasdaq - US09523Q3092 - Common Stock - Currency: USD

12.99  -0.01 (-0.08%)

After market: 12.99 0 (0%)

Fundamental Rating

1

APRN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 40 industry peers in the Consumer Staples Distribution & Retail industry. APRN may be in some trouble as it scores bad on both profitability and health. APRN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year APRN has reported negative net income.
APRN had a negative operating cash flow in the past year.
APRN had negative earnings in each of the past 5 years.
In the past 5 years APRN always reported negative operating cash flow.
APRN Yearly Net Income VS EBIT VS OCF VS FCFAPRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -50M -100M -150M -200M -250M

1.2 Ratios

Looking at the Return On Assets, with a value of -146.26%, APRN is doing worse than 90.91% of the companies in the same industry.
Industry RankSector Rank
ROA -146.26%
ROE N/A
ROIC N/A
ROA(3y)-41.24%
ROA(5y)-36.22%
ROE(3y)-169.36%
ROE(5y)-140.05%
ROIC(3y)N/A
ROIC(5y)N/A
APRN Yearly ROA, ROE, ROICAPRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 -100 -200 -300

1.3 Margins

Looking at the Gross Margin, with a value of 35.18%, APRN belongs to the top of the industry, outperforming 86.36% of the companies in the same industry.
APRN's Gross Margin has improved in the last couple of years.
APRN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.57%
GM growth 5Y3.16%
APRN Yearly Profit, Operating, Gross MarginsAPRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 -20

More info and screens

0

2. Health

2.1 Basic Checks

APRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
APRN has about the same amout of shares outstanding than it did 1 year ago.
APRN has a worse debt/assets ratio than last year.
APRN Yearly Shares OutstandingAPRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 100K 200K 300K 400K
APRN Yearly Total Debt VS Total AssetsAPRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

APRN has an Altman-Z score of -11.41. This is a bad value and indicates that APRN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -11.41, APRN is doing worse than 93.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -11.41
ROIC/WACCN/A
WACC11.65%
APRN Yearly LT Debt VS Equity VS FCFAPRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 100M -100M 200M -200M

2.3 Liquidity

A Current Ratio of 0.66 indicates that APRN may have some problems paying its short term obligations.
APRN's Current ratio of 0.66 is on the low side compared to the rest of the industry. APRN is outperformed by 88.64% of its industry peers.
A Quick Ratio of 0.63 indicates that APRN may have some problems paying its short term obligations.
APRN has a Quick ratio of 0.63. This is comparable to the rest of the industry: APRN outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.63
APRN Yearly Current Assets VS Current LiabilitesAPRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M 250M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for APRN have decreased strongly by -16.20% in the last year.
Looking at the last year, APRN shows a decrease in Revenue. The Revenue has decreased by -4.99% in the last year.
The Revenue for APRN have been decreasing by -12.25% on average. This is quite bad
EPS 1Y (TTM)-16.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.96%
Revenue 1Y (TTM)-4.99%
Revenue growth 3Y0.26%
Revenue growth 5Y-12.25%
Sales Q2Q%-14.49%

3.2 Future

The Earnings Per Share is expected to grow by 19.82% on average over the next years. This is quite good.
APRN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.20% yearly.
EPS Next Y54.45%
EPS Next 2Y37.61%
EPS Next 3Y26.25%
EPS Next 5Y19.82%
Revenue Next Year-8.95%
Revenue Next 2Y-1.64%
Revenue Next 3Y3.66%
Revenue Next 5Y5.2%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
APRN Yearly Revenue VS EstimatesAPRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
APRN Yearly EPS VS EstimatesAPRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -10 -20 -30 -40 -50

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

APRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year APRN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
APRN Price Earnings VS Forward Price EarningsAPRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
APRN Per share dataAPRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

A more expensive valuation may be justified as APRN's earnings are expected to grow with 26.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.61%
EPS Next 3Y26.25%

More info and screens

0

5. Dividend

5.1 Amount

APRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLUE APRON HOLDINGS INC-A

NASDAQ:APRN (11/10/2023, 8:00:00 PM)

After market: 12.99 0 (0%)

12.99

-0.01 (-0.08%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)11-09 2023-11-09/bmo
Earnings (Next)03-14 2024-03-14/amc
Inst Owners1.56%
Inst Owner Change0%
Ins Owners182.86%
Ins Owner Change0%
Market Cap83.53M
Analysts77.78
Price Target14.62 (12.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-83.86%
Min EPS beat(2)-188.07%
Max EPS beat(2)20.34%
EPS beat(4)2
Avg EPS beat(4)-42.67%
Min EPS beat(4)-188.07%
Max EPS beat(4)42.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.81%
Min Revenue beat(2)-4.81%
Max Revenue beat(2)-0.8%
Revenue beat(4)1
Avg Revenue beat(4)-1.79%
Min Revenue beat(4)-6.1%
Max Revenue beat(4)4.57%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-38.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.7%
EPS NY rev (1m)0%
EPS NY rev (3m)-59.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-27.4
EYN/A
EPS(NY)-3.86
Fwd EYN/A
FCF(TTM)-10.11
FCFYN/A
OCF(TTM)-9.19
OCFYN/A
SpS67.78
BVpS-2.52
TBVpS-2.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -146.26%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.18%
FCFM N/A
ROA(3y)-41.24%
ROA(5y)-36.22%
ROE(3y)-169.36%
ROE(5y)-140.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.57%
GM growth 5Y3.16%
F-Score4
Asset Turnover5.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 32.43%
Cap/Sales 1.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.63
Altman-Z -11.41
F-Score4
WACC11.65%
ROIC/WACCN/A
Cap/Depr(3y)25.92%
Cap/Depr(5y)27.6%
Cap/Sales(3y)1.28%
Cap/Sales(5y)1.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.96%
EPS Next Y54.45%
EPS Next 2Y37.61%
EPS Next 3Y26.25%
EPS Next 5Y19.82%
Revenue 1Y (TTM)-4.99%
Revenue growth 3Y0.26%
Revenue growth 5Y-12.25%
Sales Q2Q%-14.49%
Revenue Next Year-8.95%
Revenue Next 2Y-1.64%
Revenue Next 3Y3.66%
Revenue Next 5Y5.2%
EBIT growth 1Y32.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year76.33%
EBIT Next 3Y27.85%
EBIT Next 5Y21.78%
FCF growth 1Y-154.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-205.9%
OCF growth 3YN/A
OCF growth 5YN/A